The Heather Hirsch Academy is proud to offer this mini-course exclusively for healthcare professionals (DOs, MDs, PAs, NPs, and Pharmacists):

In the U.S., over 4 million breast cancer survivors face menopause and survivorship with little support from their doctors. In 2024, over 300,000 new cases of invasive breast cancer and 60,000 new DCIS cases will be diagnosed.

Inevitably, all will go through menopause, often premature, abrupt, medically or surgically induced. Most navigate menopause alone, without education and treatment options, and are denied shared decision-making about hormone therapy after breast cancer.

Join us in this course with Dr. Corinne Menn, a national leader in the field of menopause and breast cancer survivorship. Review the unique challenges breast cancer survivors have when dealing with menopause, and learn about the available scientific literature and professional society statements on hormone therapy after breast cancer. Understand how to use the data, shared decision-making, and informed consent to counsel women on their options for hormone therapy after breast cancer.